AmgRS-mediated envelope stress-inducible expression of the mexXY multidrug efflux operon of Pseudomonas aeruginosa

MicrobiologyOpen

Volumn 4, Issue 1, 2015, Pages 121-135

  Lau, Calvin Ho Fung ^a,b   Krahn, Thomas ^a   Gilmour, Christie ^a   Mullen, Erin ^a   Poole, Keith ^a  

^a QUEEN S UNIVERSITY   (Canada)

^b AGRICULTURE AND AGRI FOOD CANADA   (Canada)

Author keywords

Efflux; Envelope stress; Multidrug; Pseudomonas aeruginosa; Two component system

Indexed keywords

ARTICLE; CONTROLLED STUDY; NONHUMAN; PSEUDOMONAS AERUGINOSA; ANTIBIOTIC RESISTANCE; DRUG EFFECTS; GENE; GENE EXPRESSION REGULATION; GENETICS; MUTATION; OPERON; PHYSIOLOGICAL STRESS; PROTEIN TRANSPORT;

PSEUDOMONAS AERUGINOSA;

AMINOGLYCOSIDE; BACTERIAL PROTEIN; MEXXY PROTEIN, PSEUDOMONAS AERUGINOSA;

AMINOGLYCOSIDES; BACTERIAL PROTEINS; DRUG RESISTANCE, BACTERIAL; GENE EXPRESSION REGULATION, BACTERIAL; GENES, MDR; MUTATION; OPERON; PROTEIN TRANSPORT; PSEUDOMONAS AERUGINOSA; STRESS, PHYSIOLOGICAL;

EID: 84922887589     PISSN: None     EISSN: 20458827     Source Type: Journal    
DOI: 10.1002/mbo3.226     Document Type: Article

References (69)

1. Aakra, A., H. Vebo, L. Snipen, H. Hirt, A. Aastveit, V. Kapur, et al. 2005. Transcriptional response of Enterococcus faecalis V583 to erythromycin. Antimicrob. Agents Chemother. 49:2246-2259.
2. Aires, J. R., T. Kîhler, H. Nikaido, and P. Plesiat . 1999. Involvement of an active efflux system in the natural resistance of Pseudomonas aeruginosa to aminoglycosides. Antimicrob. Agents Chemother. 43:2624-2628.
3. Ausubel, F. M., R. Brent, R. E. Kingston, D. D. Moore, J. G. Seidman, J. A. Smith, et al. 1992. Short protocols in molecular biology. John Wiley & Sons Inc, New York, NY.
4. Breidenstein, E. B., C. de la Fuente-Nunez, and R. E. Hancock . 2011. Pseudomonas aeruginosa: all roads lead to resistance. Trends Microbiol. 19:419-426.
5. Brugha, R. E., and J. C. Davies . 2011. Pseudomonas aeruginosa in cystic fibrosis: pathogenesis and new treatments. Br. J. Hosp. Med. (Lond.) 72:614-619.
6. Busse, H. J., C. Wostmann, and E. P. Bakker . 1992. The bactericidal action of streptomycin: membrane permeabilization caused by the insertion of mistranslated proteins into the cytoplasmic membrane of Escherichia coli and subsequent caging of the antibiotic inside the cells due to degradation of these proteins. J. Gen. Microbiol. 138:551-561.
7. Caughlan, R. E., S. Sriram, D. M. Daigle, A. L. Woods, J. Buco, R. L. Peterson, et al. 2009. Fmt bypass in Pseudomonas aeruginosa causes induction of MexXY efflux pump expression. Antimicrob. Agents Chemother. 53:5015-5021.
8. Davis, B. D., L. L. Chen, and P. C. Tai . 1986. Misread protein creates membrane channels: an essential step in the bactericidal action of aminoglycosides. Proc. Natl. Acad. Sci. USA 83:6164-6168.
9. De Kievit, T. R., M. D. Parkins, R. J. Gillis, R. Srikumar, H. Ceri, K. Poole, et al. 2001. Multidrug efflux pumps: expression patterns and contribution to antibiotic resistance in Pseudomonas aeruginosa biofilms. Antimicrob. Agents Chemother. 45:1761-1770.
10. Dötsch, A., T. Becker, C. Pommerenke, Z. Magnowska, L. Jänsch, and S. Häussler . 2009. Genome-wide identification of genetic determinants of antimicrobial drug resistance in Pseudomonas aeruginosa. Antimicrob. Agents Chemother. 53:2522-2531.
11. El'Garch, F., K. Jeannot, D. Hocquet, C. Llanes-Barakat, and P. Plesiat . 2007. Cumulative effects of several nonenzymatic mechanisms on the resistance of Pseudomonas aeruginosa to aminoglycosides. Antimicrob. Agents Chemother. 51:1016-1021.
12. Fernandez, L., W. J. Gooderham, M. Bains, J. B. McPhee, I. Wiegand, and R. E. Hancock . 2010. Adaptive resistance to the "last hope" antibiotics polymyxin B and colistin in Pseudomonas aeruginosa is mediated by the novel two-component regulatory system ParR-ParS. Antimicrob. Agents Chemother. 54:3372-3382.
13. Fraud, S., and K. Poole . 2011. Oxidative stress induction of the mexXY multidrug efflux genes and promotion of aminoglycoside resistance development in Pseudomonas aeruginosa. Antimicrob. Agents Chemother. 55:1068-1074.
14. Govan, J. R., A. R. Brown, and A. M. Jones . 2007. Evolving epidemiology of Pseudomonas aeruginosa and the Burkholderia cepacia complex in cystic fibrosis lung infection. Future Microbiol. 2:153-164.
15. Guenard, S., C. Muller, L. Monlezun, P. Benas, I. Broutin, K. Jeannot, et al. 2014. Multiple mutations lead to MexXY-OprM-dependent aminoglycoside resistance in clinical strains of Pseudomonas aeruginosa. Antimicrob. Agents Chemother. 58:221-228.
16. Hay, T., S. Fraud, C. H. Lau, C. Gilmour, and K. Poole . 2013. Antibiotic inducibility of the mexXY multidrug efflux operon of Pseudomonas aeruginosa: involvement of the MexZ anti-repressor ArmZ. PLoS One 8:e56858.
17. Henrichfreise, B., I. Wiegand, W. Pfister, and B. Wiedemann . 2007. Resistance mechanisms of multiresistant Pseudomonas aeruginosa strains from Germany and correlation with hypermutation. Antimicrob. Agents Chemother. 51:4062-4070.
18. Hidron, A. I., J. R. Edwards, J. Patel, T. C. Horan, D. M. Sievert, D. A. Pollock, et al. 2008. NHSN annual update: antimicrobial-resistant pathogens associated with healthcare-associated infections: annual summary of data reported to the National Healthcare Safety Network at the Centers for Disease Control and Prevention, 2006-2007. Infect. Control Hosp. Epidemiol. 29:996-1011.
19. Hinz, A., S. Lee, K. Jacoby, and C. Manoil . 2011. Membrane proteases and aminoglycoside antibiotic resistance. J. Bacteriol. 193:4790-4797.
20. Hoang, T. T., R. R. Karkhoff-Schweizer, A. J. Kutchma, and H. P. Schweizer . 1998. A broad-host-range Flp-FRT recombination system for site-specific excision of chromosomally-located DNA sequences: application for isolation of unmarked Pseudomonas aeruginosa mutants. Gene 212:77-86.
21. Hutter, B., C. Schaab, S. Albrecht, M. Borgmann, N. A. Brunner, C. Freiberg, et al. 2004. Prediction of mechanisms of action of antibacterial compounds by gene expression profiling. Antimicrob. Agents Chemother. 48:2838-2844.
22. Inoue, H., H. Nojima, and H. Okayama . 1990. High efficiency transformation of Escherichia coli with plasmids. Gene 96:23-28.
23. Jeannot, K., M. L. Sobel, F. El Garch, K. Poole, and P. Plesiat . 2005. Induction of the MexXY efflux pump in Pseudomonas aeruginosa is dependent on drug-ribosome interaction. J. Bacteriol. 187:5341-5346.
24. Jo, J. T. H., F. S. L. Brinkman, and R. E. W. Hancock . 2003. Aminoglycoside efflux in Pseudomonas aeruginosa: involvement of novel outer membrane proteins. Antimicrob. Agents Chemother. 47:1101-1111.
25. Krahn, T., C. Gilmour, J. Tilak, S. Fraud, N. Kerr, C. H. Lau, et al. 2012. Determinants of intrinsic aminoglycoside resistance in Pseudomonas aeruginosa. Antimicrob. Agents Chemother. 56:5591-5602.
26. Lau, C. H.-F., S. Fraud, M. Jones, S. N. Peterson, and K. Poole . 2012. Reduced expression of the rplU-rpmA ribosomal protein operon in mexXY-expressing pan-aminoglycoside-resistant mutants of Pseudomonas aeruginosa. Antimicrob. Agents Chemother. 56:5171-5179.
27. Lau, C. H.-F., S. Fraud, M. Jones, S. N. Peterson, and K. Poole . 2013. Mutational activation of the AmgRS two-component system in aminoglycoside-resistant Pseudomonas aeruginosa. Antimicrob. Agents Chemother. 57:2243-2251.
28. Lee, S., A. Hinz, E. Bauerle, A. Angermeyer, K. Juhaszova, Y. Kaneko, et al. 2009. Targeting a bacterial stress response to enhance antibiotic action. Proc. Natl. Acad. Sci. USA 106:14570-14575.
29. Lin, J. T., M. B. Connelly, C. Amolo, S. Otani, and D. S. Yaver . 2005. Global transcriptional response of Bacillus subtilis to treatment with subinhibitory concentrations of antibiotics that inhibit protein synthesis. Antimicrob. Agents Chemother. 49:1915-1926.
30. Masuda, N., and S. Ohya . 1992. Cross-resistance to meropenem, cephems, and quinolones in Pseudomonas aeruginosa. Antimicrob. Agents Chemother. 36:1847-1851.
31. Masuda, N., E. Sakagawa, S. Ohya, N. Gotoh, H. Tsujimoto, and T. Nishino . 2000a. Contribution of the MexX-MexY-OprM efflux system to intrinsic resistance in Pseudomonas aeruginosa. Antimicrob. Agents Chemother. 44:2242-2246.
32. Masuda, N., E. Sakagawa, S. Ohya, N. Gotoh, H. Tsujimoto, and T. Nishino . 2000b. Substrate specificities of MexAB-OprM, MexCD-OprJ, and MexXY-OprM efflux pumps in Pseudomonas aeruginosa. Antimicrob. Agents Chemother. 44:3322-3327.
33. Matsuo, Y., S. Eda, N. Gotoh, E. Yoshihara, and T. Nakae . 2004. MexZ-mediated regulation of mexXY multidrug efflux pump expression in Pseudomonas aeruginosa by binding on the mexZ-mexX intergenic DNA. FEMS Microbiol. Lett. 238:23-28.
34. Mine, T., Y. Morita, A. Kataoka, T. Mitzushima, and T. Tsuchiya . 1999. Expression in Escherichia coli of a new multidrug efflux pump, MexXY, from Pseudomonas aeruginosa. Antimicrob. Agents Chemother. 43:415-417.
35. Morita, Y., M. L. Sobel, and K. Poole . 2006. Antibiotic inducibility of the MexXY multidrug efflux system of Pseudomonas aeruginosa: involvement of the antibiotic-inducible PA5471 gene product. J. Bacteriol. 188:1847-1855.
36. Morita, Y., C. Gilmour, D. Metcalf, and K. Poole . 2009. Translational control of the antibiotic inducibility of the PA5471 gene required for mexXY multidrug efflux gene expression in Pseudomonas aeruginosa. J. Bacteriol. 191:4966-4975.
37. Muller, C., P. Plesiat, and K. Jeannot . 2010. A two-component regulatory system interconnects resistance to polymyxins, aminoglycosides, fluoroquinolones, and ß-lactams in Pseudomonas aeruginosa. Antimicrob. Agents Chemother. 55:1211-1221.
38. Nanduri, B., L. A. Shack, S. C. Burgess, and M. L. Lawrence . 2009. The transcriptional response of Pasteurella multocida to three classes of antibiotics. BMC Genom. 10(Suppl. 2):S4.
39. Nehme, D., X. Z. Li, R. Elliot, and K. Poole . 2004. Assembly of the MexAB-OprM multidrug efflux system of Pseudomonas aeruginosa: identification and characterization of mutations in mexA compromising MexA multimerization and interaction with MexB. J. Bacteriol. 186:2973-2983.
40. Ng, W. L., K. M. Kazmierczak, G. T. Robertson, R. Gilmour, and M. E. Winkler . 2003. Transcriptional regulation and signature patterns revealed by microarray analyses of Streptococcus pneumoniae R6 challenged with sublethal concentrations of translation inhibitors. J. Bacteriol. 185:359-370.
41. Olivares, J., A. Bernardini, G. Garcia-Leon, F. Corona, M. B. Sanchez, and J. L. Martinez . 2013. The intrinsic resistome of bacterial pathogens. Front. Microbiol. 4:103.
42. Peske, F., A. Savelsbergh, V. I. Katunin, M. V. Rodnina, and W. Wintermeyer . 2004. Conformational changes of the small ribosomal subunit during elongation factor G-dependent tRNA-mRNA translocation. J. Mol. Biol. 343:1183-1194.
43. Poole, K. 2005a. Aminoglycoside resistance in Pseudomonas aeruginosa. Antimicrob. Agents Chemother. 49:479-487.
44. Poole, K. 2005b. Efflux-mediated antimicrobial resistance. J. Antimicrob. Chemother. 56:20-51.
45. Poole, K. 2011. Pseudomonas aeruginosa: resistance to the max. Front. Microbiol. 2:65. doi: 10.3389/fmicb.2011.00065
46. Poole, K. 2013. Pseudomonas aeruginosa efflux pumps. Pp. 175-206 in E. W. Yu, Q. Zhang and M. H. Brown, eds. Microbial efflux pumps: current research. Caister Academic Press, Norfolk, U.K.
47. Prayle, A., and A. R. Smyth . 2010. Aminoglycoside use in cystic fibrosis: therapeutic strategies and toxicity. Curr. Opin. Pulm. Med. 16:604-610.
48. Qiu, J., D. Zhou, Y. Han, L. Zhang, Z. Tong, Y. Song, et al. 2005. Global gene expression profile of Yersinia pestis induced by streptomycin. FEMS Microbiol. Lett. 243:489-496.
49. Ruiz, N., and T. J. Silhavy . 2005. Sensing external stress: watchdogs of the Escherichia coli cell envelope. Curr. Opin. Microbiol. 8:122-126.
50. Sabina, J., N. Dover, L. J. Templeton, D. R. Smulski, D. Soll, and R. A. LaRossa . 2003. Interfering with different steps of protein synthesis explored by transcriptional profiling of Escherichia coli K-12. J. Bacteriol. 185:6158-6170.
51. Sakoh, M., K. Ito, and Y. Akiyama . 2005. Proteolytic activity of HtpX, a membrane-bound and stress-controlled protease from Escherichia coli. J. Biol. Chem. 280:33305-33310.
52. Sambrook, J., and D. W. Russell . 2001. Molecular cloning: a laboratory manual. Cold Spring Harbor Laboratory Press, Cold Spring Harbor, NY.
53. Schäfer, A., A. Tauch, W. Jäger, J. Kalinowski, G. Thierbach, and A. Pühler . 1994. Small mobilizable multi-purpose cloning vectors derived from the Escherichia coli plasmids pK18 and pK19: selection of defined deletions in the chromosome of Corynebacterium glutamicum. Gene 145:69-73.
54. Schurek, K. N., A. K. Marr, P. K. Taylor, I. Wiegand, L. Semenec, B. K. Khaira, et al. 2008. Novel genetic determinants of low-level aminoglycoside resistance in Pseudomonas aeruginosa. Antimicrob. Agents Chemother. 52:4213-4219.
55. Shaw, K. J., N. Miller, X. Liu, D. Lerner, J. Wan, A. Bittner, et al. 2003. Comparison of the changes in global gene expression of Escherichia coli induced by four bactericidal agents. J. Mol. Microbiol. Biotechnol. 5:105-122.
56. Sheu, D. S., Y. T. Wang, and C. Y. Lee . 2000. Rapid detection of polyhydroxyalkanoate-accumulating bacteria isolated from the environment by colony PCR. Microbiology 146:2019-2025.
57. Simon, R., U. Priefer, and A. Puhler . 1983. A broad host range mobilization system for in vivo genetic engineering: transposon mutagenesis in Gram-negative bacteria. Nat. Biotechnol. 1:784-791.
58. Sobel, M. L., G. A. McKay, and K. Poole . 2003. Contribution of the MexXY multidrug transporter to aminoglycoside resistance in Pseudomonas aeruginosa clinical isolates. Antimicrob. Agents Chemother. 47:3202-3207.
59. Srikumar, R., X. Z. Li, and K. Poole . 1997. Inner membrane efflux components are responsible for beta-lactam specificity of multidrug efflux pumps in Pseudomonas aeruginosa. J. Bacteriol. 179:7875-7881.
60. van Stelten, J., F. Silva, D. Belin, and T. J. Silhavy . 2009. Effects of antibiotics and a proto-oncogene homolog on destruction of protein translocator SecY. Science 325:753-756.
61. Vazquez, D. 1974. Inhibitors of protein synthesis. FEBS Lett. 40(Suppl.):S63-S84.
62. Vettoretti, L., P. Plesiat, C. Muller, F. El Garch, G. Phan, I. Attree, et al. 2009. Efflux unbalance in Pseudomonas aeruginosa isolates from cystic fibrosis patients. Antimicrob. Agents Chemother. 53:1987-1997.
63. de Vrankrijker, A. M., T. F. Wolfs, and C. K. van der Ent . 2010. Challenging and emerging pathogens in cystic fibrosis. Paediatr. Respir. Rev. 11:246-254.
64. Wallace, B. J., P. C. Tai, and B. D. Davis . 1974. Selective inhibition of initiating ribosomes by spectinomycin. Proc. Natl. Acad. Sci. USA 71:1634-1638.
65. Weisblum, B., and J. Davies . 1968. Antibiotic inhibitors of the bacterial ribosome. Bacteriol. Rev. 32:493-528.
66. Westbrock-Wadman, S., D. R. Sherman, M. J. Hickey, S. N. Coulter, Y. Q. Zhu, P. Warrener, et al. 1999. Characterization of a Pseudomonas aeruginosa efflux pump contributing to aminoglycoside impermeability. Antimicrob. Agents Chemother. 43:2975-2983.
67. Yamamoto, M., A. Ueda, M. Kudo, Y. Matsuo, J. Fukushima, T. Nakae, et al. 2009. Role of MexZ and PA5471 in transcriptional regulation of mexXY in Pseudomonas aeruginosa. Microbiology 155:3312-3321.
68. Zhanel, G. G., M. Decorby, N. Laing, B. Weshnoweski, R. Vashisht, F. Tailor, et al. 2008. Antimicrobial-resistant pathogens in intensive care units in Canada: results of the Canadian National Intensive Care Unit (CAN-ICU) study, 2005-2006. Antimicrob. Agents Chemother. 52:1430-1437.
69. Zhanel, G. G., M. Decorby, H. Adam, M. R. Mulvey, M. McCracken, P. Lagace-Wiens, et al. 2010. Prevalence of antimicrobial-resistant pathogens in Canadian hospitals: results of the Canadian Ward Surveillance Study (CANWARD 2008). Antimicrob. Agents Chemother. 54:4684-4693.